Multiple sclerosis (MS) is a neurological disease that affects about 1 million people in the United States. Your brain contains a type of cell called a neuron, and neurons are coated in a layer of ...

A Phase 2 clinical trial testing PIPE-307, an MS experimental therapy designed to promote myelin repair, failed to meet its ...

Join the School of Medicine’s Department of Population and Quantitative Health Sciences to learn about the options available with an MS in clinical research. A webinar will be held Sunday, Dec. 20, at ...

Mesenchymal stem cell therapy shows promise for treating MS, but more research is needed on long-term safety and efficacy, a review found.

In a cohort of Black and Hispanic individuals with relapsing MS, baseline comorbidities had no significant effect on the ...

Pragmatic trials may offer one way to increase minority populations in multiple sclerosis (MS) studies, investigators for the DELIVER-MS trial suggested. Race and ethnicity did not appear to influence ...

To help clinicians diagnose multiple sclerosis, an international team of researchers zeroed in on central vein sign, paramagnetic rim lesions, and cortical lesions, and their association with clinical ...

The only pharmacy school-based program of its kind in the country, the MS in Clinical and Translational Therapeutics offers PharmD, undergraduate and health care professional students a unique ...

The Combined Bachelor’s/Master’s Degree program (CBM) is intended for highly motivated current CWRU undergraduate students who are candidates for any bachelor's ...

Multiple sclerosis (MS) is characterized by a broad array of symptoms. Despite this variability, most individuals with MS will exhibit a distinct set of symptoms during their initial clinical attack.